NCT00574496 2023-09-28
Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
Rochester Skin Lymphoma Medical Group, PLLC
Stanford University
National Cancer Institute (NCI)
M.D. Anderson Cancer Center